NOLATO AB SER.B
Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company offers catheter balloons; breathing bags; non-conductive sealing and damping silicone products; primary plastic packaging for medicines; and crimp and… Read more
Market Cap & Net Worth: NOLATO AB SER.B (NBF)
NOLATO AB SER.B (F:NBF) has a market capitalization of $1.12 Billion (€1.09 Billion) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #8336 globally and #896 in its home market, demonstrating a -3.38% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NOLATO AB SER.B's stock price €4.52 by its total outstanding shares 241783080 (241.78 Million).
NOLATO AB SER.B Market Cap History: 2018 to 2026
NOLATO AB SER.B's market capitalization history from 2018 to 2026. Data shows change from $132.65 Million to $1.12 Billion (-50.32% CAGR).
NOLATO AB SER.B Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NOLATO AB SER.B's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of NBF by Market Capitalization
Companies near NOLATO AB SER.B in the global market cap rankings as of March 19, 2026.
Key companies related to NOLATO AB SER.B by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
NOLATO AB SER.B Historical Marketcap From 2018 to 2026
Between 2018 and today, NOLATO AB SER.B's market cap moved from $132.65 Million to $ 1.12 Billion, with a yearly change of -50.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.12 Billion | -18.78% |
| 2025 | €1.38 Billion | +19.98% |
| 2024 | €1.15 Billion | +45.17% |
| 2023 | €792.25 Million | +58.65% |
| 2022 | €499.37 Million | -31.00% |
| 2021 | €723.70 Million | +57.35% |
| 2020 | €459.93 Million | +54.67% |
| 2019 | €297.37 Million | +124.17% |
| 2018 | €132.65 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of NOLATO AB SER.B was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.12 Billion USD |
| MoneyControl | $1.12 Billion USD |
| MarketWatch | $1.12 Billion USD |
| marketcap.company | $1.12 Billion USD |
| Reuters | $1.12 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.